The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

8 articles for SW Schneller


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Enantiomeric 3-deaza-1',6'-isoneplanocin and its 3-bromo analogue: Synthesis by the Ullmann reaction and their antiviral properties.EBI
Auburn University
Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors.EBI
National Institute of Diabetes
 
()-7-deazaaristeromycin lacking the hydroxymethyl substituentEBI
TBA
(+)-7-Deaza-5'-noraristeromycin as an anti-trypanosomal agent.EBI
Auburn University
Antiviral enantiomeric preference for 5'-noraristeromycin.EBI
University of South Florida
6'-Fluoro-3-deazaneplanocin: Synthesis and antiviral properties, including Ebola.EBI
Auburn University
Linear and proximal benzo-separated alkylated xanthines as adenosine-receptor antagonists.EBI
University of South Florida
Methods of treatment using modulators of SIRT2BDB
Cornell University